Vestiage is Advanced Anti-Aging Science
Dr. Burke shares our passion for finding solutions in science-based nutrition and supplements that can help people maintain a high quality active lifestyle.
Newport Beach, California (PRWEB) November 11, 2013
Vestiage, the science-based anti-aging company, announced today that noted Mayo Clinic-trained and board certified Cardiologist and anti-aging specialist Dr. Robert Burke M.D. has joined the Vestiage Advisory Committee. Dr. Burke was integral to the creation, formulation and growth of the RegiMEN™ Mens Anti-Aging System of nutraceuticals that is now a part of the Vestiage brand family. Dr Burke will continue to work with Vestiage in the development of additional products and innovations for RegiMEN™ and the other Vestiage brands.
Dr. Burke said, "I look forward to working with Vestiage in developing the next generation of Men's Health supplements."
"We are very grateful to Dr. Burke for the work he is doing and his high degree of expertise in the anti-aging field, particularly in the area of how aging impacts men," said Scott Kimball, CEO of Vestiage. "Dr. Burke shares our passion for the Vestiage mission of finding solutions in science-based nutrition and supplements that can help maintain a high quality active lifestyle.
About Vestiage
Vestiage (stock symbol "VEST") is a publicly traded anti-aging company offering premium branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the mission of extending the quality of an active lifestyle using human stem cell, marine/ocean, and cutting edge botanically based science and patented botanical ingredients and formulations to produce pure, potent products. Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com) and RegiMEN™. Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on extending the quality of an active life and human performance science that covers both the cognitive and physical realms. As clinical results validate scientific discoveries, Vestiage applies new ingredients, technology or ingredient formulations and combinations to its anti-aging products. To learn more, visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiency and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.